<p dir="ltr"><b>Hypothesis.</b> Cancer emerges preferentially in <b>microenvironments of tissue death or disuse</b> (“stagnation niches”) where oxygenation, flow, and physiologic signaling have failed. In these niches, cells default to a primitive survival program characterized by glycolytic metabolism, dedifferentiation, disordered angiogenesis, immune evasion, and niche construction—i.e., the malignant phenotype. Mutational patterns stabilize this state but are <b>not the initiating event</b>.<br><b>Prediction.</b> If the niche is <b>revitalized</b> (restored flow/oxygenation, debris cleared, inflammation resolved, normal architecture re-imposed), malignant emergence and local recurrence will fall; if the niche remains necrotic/disused, malignant emergence or recurrence remains likely even after cytoreduction.<br><b>Therapeutic corollary.</b> Treat cancer as an <b>ecosystem failure</b>: debulk, <b>condition the terrain</b>, then <b>regenerate or replace</b> the dead/disused tissue (preferably with lineage-committed cells/scaffolds), and maintain organ “use” to prevent re-stagnation.</p>